Fiera Capital Corp acquired a new stake in Merit Medical Systems, Inc. (NASDAQ:MMSI) in the second quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor acquired 261,038 shares of the medical instruments supplier’s stock, valued at approximately $9,958,000. Fiera Capital Corp owned approximately 0.52% of Merit Medical Systems as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Mason Street Advisors LLC increased its position in shares of Merit Medical Systems by 17.9% in the 1st quarter. Mason Street Advisors LLC now owns 11,491 shares of the medical instruments supplier’s stock valued at $332,000 after buying an additional 1,748 shares in the last quarter. Vanguard Group Inc. increased its position in shares of Merit Medical Systems by 16.1% in the 1st quarter. Vanguard Group Inc. now owns 4,186,883 shares of the medical instruments supplier’s stock valued at $121,001,000 after buying an additional 580,871 shares in the last quarter. MARSHALL WACE ASIA Ltd bought a new stake in shares of Merit Medical Systems in the 1st quarter valued at $15,657,000. Russell Investments Group Ltd. increased its position in shares of Merit Medical Systems by 50.4% in the 1st quarter. Russell Investments Group Ltd. now owns 28,711 shares of the medical instruments supplier’s stock valued at $830,000 after buying an additional 9,625 shares in the last quarter. Finally, Swiss National Bank increased its position in shares of Merit Medical Systems by 10.1% in the 1st quarter. Swiss National Bank now owns 81,700 shares of the medical instruments supplier’s stock valued at $2,361,000 after buying an additional 7,500 shares in the last quarter. Institutional investors and hedge funds own 89.11% of the company’s stock.

In other Merit Medical Systems news, insider Richard W. Edelman sold 20,000 shares of Merit Medical Systems stock in a transaction on Friday, June 30th. The shares were sold at an average price of $37.62, for a total value of $752,400.00. Following the completion of the sale, the insider now directly owns 35,000 shares of the company’s stock, valued at $1,316,700. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, Director F. Ann Millner sold 6,744 shares of Merit Medical Systems stock in a transaction on Wednesday, June 28th. The shares were sold at an average price of $38.15, for a total transaction of $257,283.60. Following the completion of the sale, the director now directly owns 4,247 shares of the company’s stock, valued at $162,023.05. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 100,180 shares of company stock valued at $4,013,897. Insiders own 5.00% of the company’s stock.

Merit Medical Systems, Inc. (NASDAQ:MMSI) opened at 41.50 on Friday. Merit Medical Systems, Inc. has a 12-month low of $20.70 and a 12-month high of $42.60. The firm’s 50-day moving average price is $41.11 and its 200-day moving average price is $35.35. The company has a market cap of $2.08 billion, a PE ratio of 59.12 and a beta of 1.25.

Merit Medical Systems (NASDAQ:MMSI) last posted its quarterly earnings results on Wednesday, July 26th. The medical instruments supplier reported $0.36 earnings per share for the quarter, beating the consensus estimate of $0.29 by $0.07. Merit Medical Systems had a net margin of 4.87% and a return on equity of 9.78%. The firm had revenue of $186.50 million during the quarter, compared to the consensus estimate of $181.46 million. During the same period in the previous year, the firm posted $0.26 earnings per share. The business’s revenue was up 23.4% compared to the same quarter last year. Equities research analysts forecast that Merit Medical Systems, Inc. will post $1.26 earnings per share for the current fiscal year.

TRADEMARK VIOLATION NOTICE: “Fiera Capital Corp Takes Position in Merit Medical Systems, Inc. (MMSI)” was originally reported by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are reading this report on another publication, it was stolen and reposted in violation of United States and international copyright and trademark laws. The correct version of this report can be viewed at https://www.thecerbatgem.com/2017/09/16/fiera-capital-corp-takes-position-in-merit-medical-systems-inc-mmsi.html.

A number of research firms recently commented on MMSI. Canaccord Genuity restated a “buy” rating and issued a $45.00 price objective on shares of Merit Medical Systems in a research report on Wednesday, September 6th. Raymond James Financial, Inc. restated an “outperform” rating and issued a $44.00 price objective on shares of Merit Medical Systems in a research report on Monday, August 28th. Citigroup Inc. cut shares of Merit Medical Systems from a “strong-buy” rating to an “outperform” rating and set a $44.00 price objective for the company. in a research report on Monday, August 28th. They noted that the move was a valuation call. UBS AG cut shares of Merit Medical Systems from a “strong-buy” rating to an “outperform” rating in a research report on Monday, August 28th. Finally, Piper Jaffray Companies restated a “buy” rating and issued a $45.00 price objective on shares of Merit Medical Systems in a research report on Friday, July 28th. One research analyst has rated the stock with a hold rating, eleven have issued a buy rating and one has given a strong buy rating to the company’s stock. The company has a consensus rating of “Buy” and an average price target of $41.25.

Merit Medical Systems Profile

Merit Medical Systems, Inc is a manufacturer and marketer of disposable medical devices used in a range of interventional, diagnostic and therapeutic medical procedures. The Company operates in two segments: cardiovascular and endoscopy. The cardiovascular segment consists of cardiology and radiology devices, which assist in diagnosing and treating coronary arterial disease, peripheral vascular disease and other non-vascular diseases, and includes embolotherapeutic, cardiac rhythm management (CRM), electrophysiology (EP), and interventional oncology and spine devices.

Want to see what other hedge funds are holding MMSI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Merit Medical Systems, Inc. (NASDAQ:MMSI).

Institutional Ownership by Quarter for Merit Medical Systems (NASDAQ:MMSI)

Receive News & Stock Ratings for Merit Medical Systems Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merit Medical Systems Inc. and related stocks with our FREE daily email newsletter.